Table 1:
Study | Country | Years conducteda | Sample | N people | N person yearsb |
---|---|---|---|---|---|
1. Accurso, 2015(39) | United States | 1990–2010 | People “abusing” cocaine and presenting for detoxification at Chemical Dependence Unit at John Hopkins Bayview Medical Center in Baltimore between 1990–1991 | 315 | 5780* |
2. Arendt, 2011(40) | Denmark | 1996–2006 | People receiving publicly funded treatment for illicit substance use disorder and primarily using cocaine across Denmark between 1996–2006, identified from the Danish Substance Abuse Treatment Register | 838 | 2571* |
3. Barrio, 2013(41) | Spain | 2004–2010 | People who reported regular cocaine use (≥ 52 days/last year) recruited from drug scenes and non-treatment settings in Madrid, Barcelona, and Seville, Spain, between 2004–2006 | 714 | 3922 |
4. Bohnert, 2017(23) | United States | 2006–2011 | People receiving Veteran Health Administration (VHA) care in the 2005 financial year diagnosed with cocaine use disorder and still alive in 2006 as identified using VHA National Patient Care Database | 83808 | 468560* |
5. Callaghan, 2013(22) (Callaghan, 2012(42)) | United States | 1990–2005 | People hospitalised with a cocaine use disorder diagnosis in California between 1990–2005 from the Patient Discharge Database | 48949 | 395738 |
6. de la Fuente, 2016(43) (Brugal, 2016(44); Colell, 2018(45); Molist, 2018(21)) | Spain | 1997–2008 | People starting drug treatment for cocaine use disorder in a publicly owned or funded treatment centre in Barcelona and Madrid between 1997–2007 | 11905 | 65849* |
7. Dias, 2011(46)c | Brazil | 1992–2006 | People who were consecutively admitted patients to Taipas General Hospital’s inpatient treatment for crack/cocaine dependence between 1992–1994 | 131 | 1182* |
8. Gossop, 2002(47)c | United Kingdom | 1995–1999 | People who self-reported cocaine misuse recruited to treatment programs throughout England in 1995 as part of National Treatment Outcome Research Study (NTORS) cohort | 227 | 926* |
9. Hayashi, 2016(48) (Tyndall, 2001(49)) | Canada | 1996–2011 | People who injected cocaine in the 6 months prior to enrolling in the open cohorts of Vancouver Injection Drug Users Study (VIDUS) and AIDS Care Cohort to Evaluate access to Survival Sciences (ACCESS) in Vancouver between 1996–2011 | 1719 | 11749 |
10. Hser, 2012(50) | United States | 2002–2010 | Mothers enrolled in a drug treatment program with cocaine as the primary drug of concern between 2000–2002 across California as identified through California Treatment Outcome Project (CalTOP) | 511 | 5471* |
11. Lopez, 2004 (OFDT)(51)c | France | 1992–2001 | People arrested in 1992, 1993, 1996 and 1997 for cocaine/crack use/dealing as identified through database of police questioning files for use of narcotics | 2212 | 11496 |
12. Markota, 2016(52) | United States | 1999–2011 | People aged 13–18 years old attending drug and alcohol treatment and with a positive cocaine urinary toxicology screen administered at clinical sites within Mayo Health Care System between 1999–2011 | 63 | 308* |
13. Martell, 2009^(53) | United States | 2003–2005 | People with cocaine and opioid dependence enrolled in a randomised clinical trial for cocaine vaccine from greater New Haven between 2003–2005 | 114 | 58* |
14. Nielsen, 2011(54) | Denmark | 1999–2009 | People diagnosed with cocaine abuse and at least one contact with a homeless shelter in Denmark between 1999–2009 as identified by the Danish Homeless Register | 525 | 5362* |
15. O’Driscoll, 2001(55) | United States | 1994–1997 | People who inject drugs within Seattle and King County and reported cocaine as their primary drug recruited between 1994–1996 | 340 | 931* |
16. Pavarin, 2017(56) (Pavarin, 2008(57); Pavarin, 2013(58)) | Italy | 1989–2013 | Individuals admitted to a public drug treatment for problems caused by primary use of cocaine in Bologna (North Italy) between 1989–2013 | 678 | 4753* |
17. Ryb, 2009(59) | United States | 1983–1997 | People discharged from R Adams Cowley Shock Trauma Center with a positive cocaine urinary toxicology screen at admission between 1983–1995 | 2451 | 15932* |
18. Sanvisens, 2014(60) | Spain | 1985–2008 | Patients admitted to hospital detoxification for primary cocaine abuse at one of three tertiary care facilities in Barcelona and the surrounding metropolitan area between 1985–2006 | 945 | 7155 |
19. van Haastrecht, 1996(61)c | Netherlands | 1985–1993 | People who are HIV+ and HIV- who self-reported injecting cocaine and were recruited in Amsterdam between 1985–1992 through “low-threshold” methadone programs and clinic workers for people who use drugs and engage in sex work. | 632d | 194 |
20. Vlahov, 2008(62) | United States | 1997–2002 | People who inject drugs with self-reported injecting of cocaine everyday recruited from five U.S. cities between 1997–1999 through community-based outreach methods and enrolled in the second Collaborative Injection Drug Users Study (CIDUS-II) | 102 | 486 |
21. Wang, 2005(63)c | United States | 1988–2005 | People who inject drugs who self-reported cocaine use in the previous 6 months, recruited through community in Baltimore between 1988–1989 and 1994–1998 and enrolled in AIDS Linked to Intravenous Experience study (ALIVE) | 518# | 3727 |
Note. Italics denotes associated secondary paper for the cohort;
Person years were not reported by study but calculated using formula within Appendix H;
Denotes that the study was a randomised controlled trial (RCT);
Denotes that the information was provided by the authors on request;
Period covers the start of recruitment until the end of follow-up;
Person-years were rounded to nearest whole number, though exact person-years reported were used for analysis;
Study was included in the previous review and information differs due to additional information being provided;
Study does not specify proportion of cohort that uses cocaine, but provides number of deaths within those who use cocaine.